Mohammad Khobreh — CEO
Mohammad leads the strategic direction of the fund, leveraging his extensive experience in life sciences investment. He works closely with NG Bio's limited partners and co-investors, tapping into their expertise to maximise the potential of our investments. Mohammad is particularly adept at forging strategic partnerships with major pharmaceutical companies and VC fund, regularly collaborating with them to share our deal flow and align on innovative growth opportunities. Mohammad is also deeply involved in guiding NG Bio's portfolio companies through their financing strategies, helping them navigate the complexities of growth and exit planning from the very beginning. His hands-on approach ensures that our portfolio companies are well-positioned for success in the highly competitive biotech landscape. Before co-founding NG Bio, Mohammad is a key life sciences investor at a family office, where he successfully founded and led the expansion of their life sciences strategy. Under his leadership, the portfolio achieved an impressive track record of over 3.5x returns in just six years. His responsibilities encompassed deal sourcing, due diligence, growth strategy, and exit planning. He also played a pivotal role as an Investment Committee member and served on the boards of several portfolio companies, where his insights and guidance were instrumental in driving value.
Stackforce AI infers this person is a life sciences investment expert with a focus on strategic partnerships and growth strategies.
Experience: 11 yrs 9 mos
Skills
- Business Strategy
- Leadership
Career Highlights
- Led life sciences strategy with 3.5x returns.
- Expert in strategic partnerships with pharma and VC.
- Guided portfolio companies through growth and exit.
Work Experience
University of Oxford
Business Mentor (1 yr 5 mos)
Senya Therapeutics
Investor (1 yr 11 mos)
Mesenbio
Investor (2 yrs 2 mos)
Bastion Therapeutics
Board Member (2 yrs 8 mos)
University of Nottingham
Mentor (3 yrs 5 mos)
NG Bio
Managing Director (4 yrs 5 mos)
LightOx
Investor (4 yrs 7 mos)
Abselion
Investor (5 yrs 1 mo)
Cellesce Ltd
Investor (2 yrs 1 mo)
Piccadilly Prime Ltd.
Founder - CEO (10 yrs 5 mos)
One Rosemond
Partner - Investment Committee Member (11 yrs 9 mos)
Education
Master's degree at Bayes Business School
Corporate Law and Governance at The London School of Economics and Political Science (LSE)
at University of Nottingham
A-Level at DLD College London